Clinical Trial Update: Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin with or without ZD4054 in metastatic breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ZD4054 (zibotentan)

Snippet

Sponsor: Cardiff University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: WITHDRAWN